Saline/Placebo

DRUG2 trials

Sponsors

Ohio State University, University of Copenhagen

Conditions

COVID-19HealthyPostural Orthostatic Tachycardia Syndrome (POTS)

Phase 1

Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)

Active, not recruitingNCT05881135

Ohio State UniversityCOVID-19

Start: 2023-06-06End: 2026-04-01Target: 80Updated: 2025-04-02

Unknown Phase

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

RecruitingNCT07019519

University of CopenhagenHealthy, Postural Orthostatic Tachycardia Syndrome (POTS)

Start: 2025-03-15End: 2026-09-30Target: 30Updated: 2025-06-13

Related Papers

SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure

Trials2024-05-181 citations